Aurora: a Spectrum Science company

🎉 We did it! 🎉 We’re beyond proud to announce that our Bristol Myers Squibb UK & Ireland Cancer Equals campaign picked up two wins at the PMEA Awards for… 🏆 Excellence in Public Health 🏆 Award for Patient Centricity This achievement wouldn’t have been possible without the incredible trust and collaboration from BMS, Shine Cancer Support and the people living with cancer who shared their stories and experiences with us. These awards are a testament to the strength of our long-standing partnership with BMS, allowing us to deliver such a powerful campaign that drives real impact. #WhereAbilityMeetsAgility is not just a tagline, it’s the way we work—and this award-winning campaign showcases exactly that. Our team has shown dedication to bring attention to the crucial issue of health inequalities. A massive thank you to everyone involved for their hard work, passion, and commitment. Together, we’re making a real difference! 💪 #HealthInequalities #CancerEquals #PMEAAwards2024 #Winner #WhereAbilityMeetsAgility

Creative Strategy in Medical Communications At Aurora Healthcare Communications, we believe that strategy, scientific integrity and creativity form the foundational pillars of impactful med comms. Our latest piece by Scientific Lead, Georgia Hartnell explores how these pillars are becoming increasingly important with the ever-evolving complexities of our healthcare systems. Read more here👇 #MedComms #CreativeStrategy #HealthcareInnovation #WhereAbilityMeetsAgility

Three is the magic number! We’re beyond excited to share that Aurora Healthcare Communications has been shortlisted for three categories at the PMEA Awards 2024! ✨First, Aurora is in the running for PMEA Support Agency of the Year! Our vision is to deliver innovation, change lives, and make progress possible. This recognition reflects our commitment to delivering life-changing work by partnering with clients who share our bold vision. ✨Additionally, our impactful Cancer Equals campaign, developed in collaboration with Bristol Myers Squibb, has been shortlisted in the categories for Excellence in Public Health and Award for Patient Centricity. We owe a huge thank you to Bristol Myers Squibb UK & Ireland and Shine Cancer Support for trusting us with this important work by bringing attention to health inequalities in cancer. We’re thrilled to celebrate the innovative work shaping our industry at the PMEA Awards on 21 November. Good luck to all the nominees – see you there!🍀 #PMEA2024 #WhereAbilityMeetsAgility #HealthInequalities #CancerEquals

Aurora was thrilled to attend this year’s Reuters Customer Engagement conference, represented by our Director, Joe Balfour, and Creative and Innovation Director, Sebastian Stokes. Dive into Joe’s take on what’s driving meaningful engagement in pharma today. Read the full blog here 👇 #REcustomerEU24 #WhereAbilityMeetsAgility

Last week, we joined experts at Scope Summit Europe to explore innovations in clinical trial recruitment and patient engagement.  Aurora’s Director & Head of Patient Engagement, Stephen O'Farrell shares key reflections, from the evolution of decentralised trials to the importance of patient-focused protocol design and inclusive research strategies. Read Stephen’s full insights here 👇

Joe Balfour and Sebastian Stokes are excited to be at the Reuters Conference today! It’s a fantastic two-day event, so if you’re attending, reach out—they’d love to connect over coffee! #REcustomerEU24 #WhereAbilityMeetsAgility

Our team are going to be at some important meetings over the next month to learn about the latest developments in communications and reputation; patient engagement; clinical trial experience; and the latest on the commercial landscape and outlook for biopharma and biotech. If you’re going to be joining them, let us know. It’d be great to connect and catch-up with faces new and old. Here’s where you can find us: 🔹 SCOPE Europe 📅 October 29-30, 2024 📍 Barcelona, Spain 📩 Connect with Aurora’s Director & Head of Patient Engagement, Stephen O'Farrell (stephen.ofarrell@auroracomms.com) and President at Continuum Clinical, A Spectrum Science Company, Neil Weisman (NWeisman@continuumclinical.com) 🔹 Reuters, Pharma Customer Engagement Europe 2024 📅 November 4-5, 2024 📍 London, UK 📩 Connect with Aurora’s Creative and Innovation Director Sebastian Stokes (sebastian.stokes@auroracomms.com) and Director Joe Balfour (joe.balfour@auroracomms.com) 🔹 Pharma & Healthcare Comms & Reputation Conference 📅 November 26, 2024 📍 London, UK 📩 Connect with Aurora’s Directors Claire Murray (claire.murray@auroracomms.com) and Joe Balfour (joe.balfour@auroracomms.com) We’re looking forward to sharing our learnings and insights, so if you’re attending any of these events, let’s meet up and discuss how we can work together! 🤝 #WhereAbilityMeetsAgility #SCOPEsummit #REcustomerEU24 #MedTech #PharmaInnovation #ClinicalTrials #HealthcareComms

It was fantastic to be with our GHMC - Global Health Marketing & Communications partners at our AGM in Milan, brilliantly hosted by our colleagues in Connexia. We discussed everything. The use of AI to drive productivity and promote agility; how to build resilience into our businesses; and importantly spent time strengthening how we can work better to achieve outcomes for our clients. As European Hub lead, it was great to spend time with our Partners across the world. It's been a challenging year for many, but together, we have much to be proud of. I wrote about how Global (or Glocal) approaches are vital as we look to the next horizon of scientific innovation and the potential for life-changing outcomes they bring. To do so, it's time we embraced change. It's clear that everyone in our GHMC network believes that too.

October is #HealthLiteracyMonth, an important reminder about the importance of making health information accessible, easy to understand and inclusive 📖 At Aurora, we are proud to be a certified Patient Information Forum Trusted Information Creator, meaning that the health information we develop with our clients is evidence-based, clear, and patient-focused. By focussing on producing health information to the highest possible standards, we aim to help patients better understand their health, navigate their care with confidence and avoid accepting health misinformation as fact.  If you want to learn more about the importance of accurate and accessible information in combating health misinformation, check out our Re_frame the Future episode where Stephen O'Farrell speaks to Dan Wills⚡ #HealthEquity #PatientSupport #WhereAbilityMeetsAgility 

As we gather for our GHMC - Global Health Marketing & Communications AGM in Milan, Italy, we're thrilled to reconnect with our GHMC partners from around the world. This event is a fantastic opportunity to share inspiring ideas and knowledge and continue innovating in the industry together🌍 In the context of our discussions, we are addressing the challenges facing the pharmaceutical industry, particularly the ongoing global innovation recession. With pandemic recovery, rising inflation, and political instability, the life sciences sector—usually resilient—has seen unprecedented drops in investment and clinical trial starts. So, how do we reignite innovation? Our Managing Director, Chris Bath, addresses this in his latest blog, emphasising the importance of thinking ‘Glocal’🌎 By embracing both global and local perspectives, we can revitalise the industry. Success in life sciences requires understanding and integrating local market dynamics within a global framework, from clinical trial recruitment to commercial strategies and market access planning. 👉 Read Chris Bath’s full blog on how thinking ‘Glocal’ can help the pharmaceutical industry overcome its innovation recession. https://lnkd.in/g2Sm4z4s